Clinical Trials Browser

Phase 1/2 × Enrolling by invitation × Ovarian Neoplasms × Clear all

NCT03393962 2026-04-24

Intervention of Ovarian Cancer With Antigen-specific Engineered Immune Effectors

Phase 1/2 Enrolling by invitation

Ovarian Neoplasms